Stock Events

Stock Events

Biosenic

$4.20

33

+$0.00+0% Thursday 16:30

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

131.16M

P/E Ratio

0

Dividend Yield

-

Dividend

-

Earnings

20MayExpected

Q3 2022

Q4 2022

Q1 2023

Q2 2023

Q3 2023

Q4 2023

Q1 2024

0

0.33

0.67

1

Expected EPS

N/A

Actual EPS

N/A

Financials

-Profit Margin

Unprofitable

2017

2018

2019

2020

2021

2022

0Revenue

-2.11MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with Biosenic's offerings.

Thermo Fisher Scientific

Thermo Fisher Scientific offers a broad range of biotechnology products, including genomics and proteomics tools, which overlap with Biosenic's market.

Qiagen is known for sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics and research market.

Bio-Rad Laboratories

Bio-Rad Laboratories manufactures and supplies products and systems used for gene expression, protein purification, and analysis, which are areas Biosenic may also operate in.

Pacific Biosciences of California

Pacific Biosciences offers long-read sequencing technologies, which can be seen as complementary or competitive to Biosenic's offerings depending on their focus in genomics.

Agenus is involved in immuno-oncology, a field that may overlap with Biosenic's work if they are involved in developing therapies or diagnostics based on genetic information.

Guardant Health

Guardant Health focuses on liquid biopsies and cancer diagnostics through genomic sequencing, competing in the precision medicine space.

Intellia Therapeutics

Intellia Therapeutics is a leading genome editing company, which could be a competitor if Biosenic is involved in therapeutic applications of genomics.

CRISPR Therapeutics

CRISPR Therapeutics is focused on developing gene-based medicines, potentially competing with Biosenic if they are involved in therapeutic genomics.

About

Biotechnology

Health Technology

BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company offers arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms. It also provides medicinal products, including ArsciMed, an intravenous drug to treat autoimmune diseases. In addition, the company develops 4P004v which is in Phase I clinical trial for veterinary use. BioSenic S.A. is headquartered in Saintes, Belgium.

Show more...

CEO

Miguel Forte

Country

Belgium

ISIN

BE0974280126

WKN

000A14NHV

Listings

0 Comments

Share your thoughts

FAQ

What is Biosenic stock price today?▼

The current price of BNZPF is $4.20 USD — it has increased by +0% in the past 24 hours. Watch Biosenic stock price performance more closely on the chart.

What is Biosenic stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Biosenic stocks are traded under the ticker BNZPF.

What is Biosenic market cap?▼

Today Biosenic has the market capitalization of 131.16M

What were Biosenic earnings last quarter?▼

BNZPF earnings for the last quarter are -0.22 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.

What is Biosenic revenue for the last year?▼

Biosenic revenue for the last year amounts to 0 USD.

What is Biosenic net income for the last year?▼

BNZPF net income for the last year is -2.11M USD.

In which sector is Biosenic located?▼

Biosenic operates in the Technology sector.

When did Biosenic complete a stock split?▼

Biosenic has not had any recent stock splits.

Where is Biosenic headquartered?▼

Biosenic is headquartered in Gosselies, Belgium.